These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 20957396)

  • 21. Fructose-mediated non-enzymatic glycation: sweet coupling or bad modification.
    Schalkwijk CG; Stehouwer CD; van Hinsbergh VW
    Diabetes Metab Res Rev; 2004; 20(5):369-82. PubMed ID: 15343583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective role of antioxidative food factors in oxidative stress caused by hyperglycemia.
    Osawa T; Kato Y
    Ann N Y Acad Sci; 2005 Jun; 1043():440-51. PubMed ID: 16037265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Amadori product on protein: structure and reactions.
    Baynes JW; Watkins NG; Fisher CI; Hull CJ; Patrick JS; Ahmed MU; Dunn JA; Thorpe SR
    Prog Clin Biol Res; 1989; 304():43-67. PubMed ID: 2675036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advanced glycation end-products and the progress of diabetic vascular complications.
    Jakus V; Rietbrock N
    Physiol Res; 2004; 53(2):131-42. PubMed ID: 15046548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein glycation: creation of catalytic sites for free radical generation.
    Yim MB; Yim HS; Lee C; Kang SO; Chock PB
    Ann N Y Acad Sci; 2001 Apr; 928():48-53. PubMed ID: 11795527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advanced glycation end products and receptor-oxidative stress system in diabetic vascular complications.
    Yamagishi S
    Ther Apher Dial; 2009 Dec; 13(6):534-9. PubMed ID: 19954478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protein crosslinking by the Maillard reaction: dicarbonyl-derived imidazolium crosslinks in aging and diabetes.
    Chellan P; Nagaraj RH
    Arch Biochem Biophys; 1999 Aug; 368(1):98-104. PubMed ID: 10415116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitors of advanced glycation end product formation and neurovascular dysfunction in experimental diabetes.
    Cameron NE; Gibson TM; Nangle MR; Cotter MA
    Ann N Y Acad Sci; 2005 Jun; 1043():784-92. PubMed ID: 16037306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ion-trap tandem mass spectrometric analysis of Amadori-glycated phosphatidylethanolamine in human plasma with or without diabetes.
    Nakagawa K; Oak JH; Higuchi O; Tsuzuki T; Oikawa S; Otani H; Mune M; Cai H; Miyazawa T
    J Lipid Res; 2005 Nov; 46(11):2514-24. PubMed ID: 16150834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Advanced glycosylation end products and chronic complications of diabetes mellitus].
    Méndez JD
    Gac Med Mex; 2003; 139(1):49-55. PubMed ID: 12666409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Substituted benzenediol Schiff bases as promising new anti-glycation agents.
    Choudhary MI; Abbas G; Ali S; Shuja S; Khalid N; Khan KM; Atta-ur-Rahman ; Basha FZ
    J Enzyme Inhib Med Chem; 2011 Feb; 26(1):98-103. PubMed ID: 20583858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Possible participation of advanced glycation end products in the pathogenesis of colorectal cancer in diabetic patients.
    Yamagishi S; Nakamura K; Inoue H; Kikuchi S; Takeuchi M
    Med Hypotheses; 2005; 64(6):1208-10. PubMed ID: 15823719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advanced glycation endproducts: what is their relevance to diabetic complications?
    Ahmed N; Thornalley PJ
    Diabetes Obes Metab; 2007 May; 9(3):233-45. PubMed ID: 17391149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and quantification of phosphatidylethanolamine-derived glucosylamines and aminoketoses from human erythrocytes--influence of glycation products on lipid peroxidation.
    Breitling-Utzmann CM; Unger A; Friedl DA; Lederer MO
    Arch Biochem Biophys; 2001 Jul; 391(2):245-54. PubMed ID: 11437356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemical modification of proteins by methylglyoxal.
    Degenhardt TP; Thorpe SR; Baynes JW
    Cell Mol Biol (Noisy-le-grand); 1998 Nov; 44(7):1139-45. PubMed ID: 9846896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amadori-glycated phosphatidylethanolamine, a potential marker for hyperglycemia, in streptozotocin-induced diabetic rats.
    Sookwong P; Nakagawa K; Fujita I; Shoji N; Miyazawa T
    Lipids; 2011 Oct; 46(10):943-52. PubMed ID: 21732214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of deoxy-D-fructosyl phosphatidylethanolamine as a non-enzymic glycation product of phosphatidylethanolamine and its occurrence in human blood plasma and red blood cells.
    Lertsiri S; Shiraishi M; Miyazawa T
    Biosci Biotechnol Biochem; 1998 May; 62(5):893-901. PubMed ID: 9648220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The glucose, glycotoxins and glycation products: the involvement into pathogenesis of microangiopathies, arteriolosclerosis and atherosclerosis].
    Titov VN; Shiriaeva IuK
    Klin Lab Diagn; 2011 Nov; (11):3-13. PubMed ID: 22312908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advanced glycation end products and diabetic cardiovascular disease.
    Prasad A; Bekker P; Tsimikas S
    Cardiol Rev; 2012; 20(4):177-83. PubMed ID: 22314141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tandem mass spectrometry analysis of Amadori-glycated phosphatidylethanolamine in human plasma.
    Miyazawa T; Oak JH; Nakagawa K
    Ann N Y Acad Sci; 2005 Jun; 1043():280-3. PubMed ID: 16037249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.